Drug Eluting Contact Lenses
Drug Eluting Contact Lenses
批准号:
7708640
负责人:
Joseph B. Ciolino
金额:
$20.76万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2014-08-31
关键词:
Adverse effectsAnimal Disease ModelsAnimal ModelAnimalsAnti-Bacterial AgentsAntibiotic TherapyAntibioticsAqueous HumorBandageBasic ScienceBiologicalChemical EngineeringClinicalCompetenceContact LensesCorneaDevelopmentDevicesDiseaseDoctor of PhilosophyDropsDrug CombinationsDrug Delivery SystemsDrug EvaluationDrug usageEarEducationEvaluationEyeEye diseasesEyedropsFellowshipFilmFosteringGlaucomaGoalsHypersensitivityIn VitroInstitutesInstructionKeratitisKineticsMassachusettsMedicalMentorsMicrobiologyOphthalmologic Surgical ProceduresOphthalmologyOryctolagus cuniculusPatientsPharmaceutical PreparationsPhysiologicalPolymersProcessResearchResearch PersonnelResearch Project GrantsResidenciesSafetyScientistSelf-AdministeredSolutionsStagingSystemTechniquesTechnologyTimeTissue EngineeringTrainingTraining and EducationUniversitiesWorkabsorptionbiomaterial compatibilitycareer developmentcompliance behaviorcontrolled releasedesigndrug modificationin vivointerestmembernext generationprogramsresearch studyskillstreatment effect
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): After completing my ophthalmology residency, I began a unique 2 year cornea fellowship at Massachusetts Eye & Ear Infirmary (MEEI). During the first year, I worked nearly exclusively on basic science research at Massachusetts Institute of Technology (MIT) in the Langer Lab, mentored by Daniel Kohane, MD, PhD and Claes Dohlman, MD, PhD. Along with cornea tissue engineering projects, we developed a drug-eluting contact lens. My principal clinical interest is in the treatment of cornea diseases. For most patients there is no alternative to topical solutions (drops) for medications such as antibiotics used after eye surgery. In addition, bandage contact lenses are often used in conjunction with antibiotics. This research will endeavor to create a new mode of ocular drug delivery: drug-eluting contact lenses. The benchtop research will continue with experiments in design modification and drug release studies before progressing to animal studies. The in vivo research follows a natural progression from studying the drug-eluting contact lens's effect under normal, physiologic conditions to its use as a treatment of disease (bacterial keratitis and glaucoma). This mentored research project in chemical engineering, microbiology, and ocular drug delivery, in conjunction with the appropriate coursework, aims to develop competence in biotechnological approaches to medical problems and ocular drug delivery. I will continue the research under my current mentor Daniel Kohane, an expert in polymer drug delivery, and James Chodosh, an expert in animal disease models. MEEI is a leader in ophthalmic research. MIT's Langer lab offers a world-class education in polymer technology. The research will be conducted with the support of a team of scientists and clinician-scientists who have mentored over a 100 private investigators in university settings. The personal relationship that I already have with the team members will be enriched by their expertise in their respective fields. They will help me to accomplish the research aims and mentor my career development. Thus, this program will foster the abilities and approach necessary to train me to become an independent investigator and possibly a leader in the next generation of clinician-scientists. RELEVANCE (See instructions): Drug eluting contact lenses would provide an alternative to eye drops, which are inefficient delivery system that can be difficult to self-administer, contain allergy-inducing preservatives, have a limited contact time with the eye, and cannot be used for many medications. More importantly, they would offer the possibility of treating eye diseases with a host of medications that cannot currently be delivered in a drop form.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
VRC Inhibiting p38 to Prevent and Restore Corneal Scarring
-
批准号:10833743
-
项目类别:
-
资助金额:$25.08万
-
财政年份:2023
-
负责人:Joseph B. Ciolino
-
依托单位:
Anesthetic-Eluting Contact Lens for Corneal Pain
-
批准号:10646991
-
项目类别:
-
资助金额:$112.09万
-
财政年份:2023
-
负责人:Joseph B. Ciolino
-
依托单位:
Drug Eluting Contact Lenses
-
批准号:8139783
-
项目类别:
-
资助金额:$21.84万
-
财政年份:2009
-
负责人:Joseph B. Ciolino
-
依托单位:
Drug Eluting Contact Lenses
-
批准号:8531942
-
项目类别:
-
资助金额:$23.0万
-
财政年份:2009
-
负责人:Joseph B. Ciolino
-
依托单位:
Drug Eluting Contact Lenses
-
批准号:8320300
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2009
-
负责人:Joseph B. Ciolino
-
依托单位:
Drug Eluting Contact Lenses
-
批准号:7922001
-
项目类别:
-
资助金额:$21.28万
-
财政年份:2009
-
负责人:Joseph B. Ciolino
-
依托单位:
Corneal Epithelial-Stromal Interactions During Regeneration and Fibrosis
-
批准号:9893920
-
项目类别:
-
资助金额:$49.25万
-
财政年份:1984
-
负责人:Joseph B. Ciolino
-
依托单位:
Corneal Epithelial-Stromal Interactions During Regeneration and Fibrosis
-
批准号:10521703
-
项目类别:
-
资助金额:$52.47万
-
财政年份:1984
-
负责人:Joseph B. Ciolino
-
依托单位:
海外基金